Anthony D Sung
Adjunct Associate Professor of MedicineOverview
I am dedicated to the treatment of hematologic malignancies through cellular therapies such as hematopoietic stem cell transplantation (HCT). My research focuses on strategies to reduce complications of HCT and ranges from preclinical studies using murine models of HCT to Phase 1 and Phase 2 clinical trials. Areas of interest include the role of the microbiota (the trillions of bacteria living in and on our bodies), nutrition, and exercise in modulating HCT outcomes such as graft-versus-host disease (GVHD) and infections. In addition to advancing new pharmacological and cellular immunotherapies in support of these goals, we also are developing mobile health technologies (mHealth) to monitor patients at home, both as part of our innovative home transplant program as well as to improve follow up care of all our patients when they return home after transplant.
Positions
Adjunct Associate Professor of Medicine in the School of Medicine
2024 School of Medicine
Member of the Duke Cancer Institute in the School of Medicine
2016 School of Medicine
Senior Fellow in the Center for the Study of Aging and Human Development in the School of Medicine
2020 School of Medicine
Education
M.D. 2008
2008 Harvard University
Residency, OSLER MEDICAL HOUSESTAFF TRAINING PROGRAM
2011 Johns Hopkins University, School of Medicine
Fellowship, HEMATOLOGY-ONCOLOGY
2014 Duke University, School of Medicine
Publications, Grants & Awards
DCI Centers, Cancer Types & Labs
Offices & Contact
Cellular Therapy ABMT
Durham, NC
27712
Box 3961 Med Ctr
Durham, NC
27710